OAB is a common and chronic condition that can significantly impact quality of life (QoL). The primary treatment objectives are to decrease the frequency of bothersome symptoms and deliver benefits that patients find meaningful. Antimuscarinic medications are a well-established pharmacological option for alleviating OAB symptoms and enhancing QoL.^3d

Although OAB is not inherently life-threatening, its symptoms can be bothersome, negatively impacting various aspects of health-related quality of life, including sexuality and emotional well-being. This often leads to increased healthcare costs.^1o

...